Á Salamon

1.3k total citations
20 papers, 150 citations indexed

About

Á Salamon is a scholar working on Genetics, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Á Salamon has authored 20 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Á Salamon's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Genetic factors in colorectal cancer (3 papers). Á Salamon is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Genetic factors in colorectal cancer (3 papers). Á Salamon collaborates with scholars based in Hungary, United States and Romania. Á Salamon's co-authors include Imre Lengyel, Tünde Kristóf, Gyula Dávid, Károly Palatka, David J. Sturdy, Péter L. Lakatos, Mária Papp, János Banai, Pál Miheller and Ferenc Nagy and has published in prestigious journals such as Gastroenterology, European Heart Journal and Journal of Crohn s and Colitis.

In The Last Decade

Á Salamon

20 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Á Salamon Hungary 7 54 33 33 22 22 20 150
Yuriy Mostovoy Ukraine 7 41 0.8× 39 1.2× 27 0.8× 15 0.7× 31 1.4× 72 155
Ugo Pradal Italy 12 24 0.4× 50 1.5× 13 0.4× 35 1.6× 9 0.4× 17 307
MG Chapman Australia 7 14 0.3× 37 1.1× 12 0.4× 31 1.4× 144 6.5× 10 281
William A. Davis United States 9 28 0.5× 10 0.3× 23 0.7× 14 0.6× 23 1.0× 26 420
V. Datta United Kingdom 7 48 0.9× 16 0.5× 14 0.4× 34 1.5× 26 1.2× 14 194
İbrahim Demirci Türkiye 9 30 0.6× 21 0.6× 8 0.2× 31 1.4× 5 0.2× 28 206
Majed Saeed Alshahrani Saudi Arabia 8 24 0.4× 41 1.2× 14 0.4× 40 1.8× 49 2.2× 62 245
James Lucas United Kingdom 6 67 1.2× 60 1.8× 75 2.3× 32 1.5× 14 0.6× 18 158
M. Rocca Italy 13 16 0.3× 5 0.2× 25 0.8× 49 2.2× 72 3.3× 20 515
Euler Roberto Fernandes Manenti Brazil 7 14 0.3× 13 0.4× 20 0.6× 22 1.0× 4 0.2× 16 125

Countries citing papers authored by Á Salamon

Since Specialization
Citations

This map shows the geographic impact of Á Salamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Á Salamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Á Salamon more than expected).

Fields of papers citing papers by Á Salamon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Á Salamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Á Salamon. The network helps show where Á Salamon may publish in the future.

Co-authorship network of co-authors of Á Salamon

This figure shows the co-authorship network connecting the top 25 collaborators of Á Salamon. A scholar is included among the top collaborators of Á Salamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Á Salamon. Á Salamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farkas, Nelli, Renáta Bor, Anna Fábián, et al.. (2024). Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab. Biomedicines. 12(1). 158–158. 4 indexed citations
2.
3.
Kim, Yong‐Hwan, Olga Alexeeva, М. Ф. Осипенко, et al.. (2017). DOP061 Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety results. Journal of Crohn s and Colitis. 11(suppl_1). S62–S62. 13 indexed citations
4.
5.
Lakatos, Péter L., et al.. (2013). P321 Vitamin D level doesn't correlate with disease extent and severity in Hungarian patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 7. S138–S138. 1 indexed citations
6.
Lakatos, Péter L., et al.. (2013). Tu1140 Is It Necessary to Perform X-Ray Absorptiometry in Young IBD Patients to Predict the Risk of Fracture?. Gastroenterology. 144(5). S–773. 1 indexed citations
7.
Lakatos, Péter L., Miklós Tóth, Á Salamon, et al.. (2013). Vitamin D level in Hungarian patients with inflammatory bowel diseases. Orvosi Hetilap. 154(46). 1821–1828. 5 indexed citations
8.
Salamon, Á, et al.. (2012). The real face of juvenile polyposis syndrome.. PubMed. 3(4). 362–8. 4 indexed citations
9.
Miheller, Pál, L. Lakatos, Áron Vincze, et al.. (2011). Predictors of efficacy, mucosal healing and dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary. Zeitschrift für Gastroenterologie. 49(5). 1 indexed citations
10.
Miheller, Pál, Tamás Molnár, Péter L. Lakatos, et al.. (2010). W1324 Medium Term Efficacy, Mucosal Healing and Safety of Adalimumab Therapy in Patients With Crohn's Disease. National Data From Hungary. Gastroenterology. 138(5). S–699. 1 indexed citations
11.
Leblanc, Thierry, Á Salamon, Benoît Brethon, et al.. (2010). L’adolescent en rémission complète du cancer: à propos d’une étude exploratoire. Psycho-Oncologie. 4(S1). 8–12. 2 indexed citations
12.
Lakatos, Péter L., Gyula Dávid, Lajos S. Kiss, et al.. (2010). Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease. Orvosi Hetilap. 151(7). 250–258. 3 indexed citations
13.
Lakatos, Péter L., Gyula Dávid, Lajos S. Kiss, et al.. (2009). Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 4(3). 283–290. 38 indexed citations
14.
Lakatos, Péter L., Gyula Dávid, Károly Palatka, et al.. (2009). S1162 Adherence to Therapy and Use of Complementary and Alternative Medicine in Patients with Inflammatory Bowel Diseases. Gastroenterology. 136(5). A–203. 2 indexed citations
15.
Howe, James R., et al.. (2008). A family with two consecutive nonsense mutations in BMPR1A causing juvenile polyposis. Cancer Genetics and Cytogenetics. 181(1). 52–54. 6 indexed citations
16.
Salamon, Á, et al.. (1999). [The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis].. PubMed. 140(42). 2339–43. 18 indexed citations
17.
18.
Salamon, Á, et al.. (1990). [Classification of polytraumatized patients, experience with the ISS system].. PubMed. 33(3). 191–6. 1 indexed citations
19.
20.
Sturdy, David J., et al.. (1972). Das volkerwanderungszeitliche Graberfeld von Kornye. Man. 7(3). 492–492. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuriy Mostovoy Breakdown of academic impact, for papers by Ugo Pradal Breakdown of academic impact, for papers by MG Chapman Breakdown of academic impact, for papers by William A. Davis Breakdown of academic impact, for papers by V. Datta Breakdown of academic impact, for papers by İbrahim Demirci Breakdown of academic impact, for papers by Majed Saeed Alshahrani Breakdown of academic impact, for papers by James Lucas Breakdown of academic impact, for papers by M. Rocca Breakdown of academic impact, for papers by Euler Roberto Fernandes Manenti
Rankless by CCL
2026